{"DataElement":{"publicId":"2636914","version":"1","preferredName":"Patient Person Dose-Limiting Toxicity Nonevaluable Reason","preferredDefinition":"Text reason for a patient's inability to be included for dose-limiting toxicity (DLT) evaluation. [Manually-curated]","longName":"PT_DLT_NONEVAL_RSN","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2636744","version":"1","preferredName":"Patient Person Dose Limiting Toxicity Evaluation","preferredDefinition":"Inclusion of a patient in an evaluation of the dose-limiting toxicity associated with a trial; when dose-limiting toxicity is achieved, the maximum amount of agent that can be tolerated has been administered to the patient. [Manually-curated]","longName":"PT_DLT_EVAL","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2636741","version":"1","preferredName":"Patient Person","preferredDefinition":"A person who requires medical care.:Person; a human being.","longName":"C16960:C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FF7C189-555E-54C6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"ONEDATA","dateModified":"2007-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2636742","version":"1","preferredName":"Dose-Limiting Toxicity Evaluation","preferredDefinition":"Describes side effects of a drug or other treatment that are serious enough to prevent an increase in dose or level of that treatment.:Toxicity; the degree to which something is poisonous.:Evaluation; the act of placing value on something.","longName":"C28014:C27990:C25214","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose-Limiting","conceptCode":"C28014","definition":"Describes side effects of a drug or other treatment that are serious enough to prevent an increase in dose or level of that treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FF7C189-5570-54C6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"ONEDATA","dateModified":"2007-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FF7C189-5581-54C6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2636906","version":"1","preferredName":"Dose-Limiting Toxicity Unevaluable Reason","preferredDefinition":"Text terms to describe the reasons that a subject cannot be included in an evaluation of dose-limiting toxicity (DLT). [Manually-curated]","longName":"DLT_UNEVAL_RSN","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Tumor-associated complication","valueDescription":"Tumor-associated complication","ValueMeaning":{"publicId":"2636907","version":"1","preferredName":"Tumor-associated complication","longName":"2636907","preferredDefinition":"Tumor-associated complication","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FFA293A-B9D6-17F5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FFA293A-B9F0-17F5-E044-0003BA3F9857","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"REEVESD","dateModified":"2007-05-08","deletedIndicator":"No"},{"value":"Rapidly progressing disease","valueDescription":"Rapidly progressing disease","ValueMeaning":{"publicId":"2636908","version":"1","preferredName":"Rapidly progressing disease","longName":"2636908","preferredDefinition":"Rapidly progressing disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FFA293A-B9FC-17F5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FFA293A-BA16-17F5-E044-0003BA3F9857","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"REEVESD","dateModified":"2007-05-08","deletedIndicator":"No"},{"value":"Toxicity resulting in dose reduction/noncompletion","valueDescription":"Toxicity resulting in dose reduction/noncompletion","ValueMeaning":{"publicId":"2636909","version":"1","preferredName":"Toxicity resulting in dose reduction/noncompletion","longName":"2636909","preferredDefinition":"Toxicity resulting in dose reduction/noncompletion","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FFA293A-BA22-17F5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FFA293A-BA3C-17F5-E044-0003BA3F9857","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"REEVESD","dateModified":"2007-05-08","deletedIndicator":"No"},{"value":"Grade 3-4 Nonhematologic toxicity","valueDescription":"Grade 3-4 Nonhematologic toxicity","ValueMeaning":{"publicId":"2636910","version":"1","preferredName":"Grade 3-4 Nonhematologic toxicity","longName":"2636910","preferredDefinition":"Grade 3-4 Nonhematologic toxicity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FFA293A-BA48-17F5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FFA293A-BA62-17F5-E044-0003BA3F9857","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"REEVESD","dateModified":"2007-05-08","deletedIndicator":"No"},{"value":"Grade 3-4 Thrombocytopenia","valueDescription":"Grade 3-4 Thrombocytopenia","ValueMeaning":{"publicId":"2636911","version":"1","preferredName":"Grade 3-4 Thrombocytopenia","longName":"2636911","preferredDefinition":"Grade 3-4 Thrombocytopenia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FFA293A-BA6E-17F5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FFA293A-BA88-17F5-E044-0003BA3F9857","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"REEVESD","dateModified":"2007-05-08","deletedIndicator":"No"},{"value":"Grade 3-4 Febrile Neutropenia","valueDescription":"Grade 3-4 Febrile Neutropenia","ValueMeaning":{"publicId":"2636912","version":"1","preferredName":"Grade 3-4 Febrile Neutropenia","longName":"2636912","preferredDefinition":"Grade 3-4 Febrile Neutropenia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FFA293A-BA94-17F5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FFA293A-BAAE-17F5-E044-0003BA3F9857","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"REEVESD","dateModified":"2007-05-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2636905","version":"1","preferredName":"Dose-Limiting Toxicity Unevaluable Reason","preferredDefinition":"Describes side effects of a drug or other treatment that are serious enough to prevent an increase in dose or level of that treatment.:Toxicity; the degree to which something is poisonous.:Unable to be evaluated.:An explanation of the cause of some phenomenon or action.","longName":"C28014:C27990:C62222:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose-Limiting","conceptCode":"C28014","definition":"Describes side effects of a drug or other treatment that are serious enough to prevent an increase in dose or level of that treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FFA292F-6621-03AB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"ONEDATA","dateModified":"2007-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FFA292F-6632-03AB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812573","version":"1","longName":"Albert Einstein Medical Center","context":"NCIP"},{"publicId":"2812815","version":"1","longName":"Albert Einstein New CDEs","context":"NCIP"},{"publicId":"2812829","version":"1","longName":"AE_NCI_7703","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Reason patient is non-evaluab","type":"Preferred Question Text","description":"Reason patient is non-evaluable for dose-limiting toxicity","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2FFA3C40-780A-1F6B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-08","modifiedBy":"REEVESD","dateModified":"2007-06-21","changeDescription":"Curated to support Albert Einstein adoption of C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}